Metraipolis › archive › dc_98795fadddc3

Safety assessment of ustekinumab in inflammatory bowel disease: a real-world analysis based on the FDA adverse event reporting system (FAERS) — Europe PMC PMID:41390741

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41390741
DOI
10.1186/s40001-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-07T16:20:21.219Z
SHA-256 of the archived text
11150ed3e222ed27bf7620f9272cefa9f2cb06c1a0849c7972b80f3fcc0e44f3
Stable URL of this page
https://metraipolis.com/documento/dc_98795fadddc3

How to cite

Safety assessment of ustekinumab in inflammatory bowel disease: a real-world analysis based on the FDA adverse event reporting system (FAERS) — Europe PMC PMID:41390741 — Europe PMC (en), https://europepmc.org/article/MED/41390741 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_98795fadddc3 (Metraipolis archive dc_98795fadddc3, sha256 11150ed3e222ed27bf7620f9272cefa9f2cb06c1a0849c7972b80f3fcc0e44f3)
BibTeX
@misc{dc98795fadddc3,
  title = {Safety assessment of ustekinumab in inflammatory bowel disease: a real-world analysis based on the FDA adverse event reporting system (FAERS) — Europe PMC PMID:41390741},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41390741},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_98795fadddc3; sha256 11150ed3e222ed27bf7620f9272cefa9f2cb06c1a0849c7972b80f3fcc0e44f3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41390741. Agents can read the archived copy with the MCP tool read_document.